Speaker illustration

Professor Tim Friede

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

Since January 2010 Tim Friede is Professor of Biostatistics at the University Medical Center Göttingen where he heads up the Department of Medical Statistics. He graduated in Mathematics (Dipl.-Math.) from the University of Karlsruhe and obtained a PhD (Dr.sc.hum.) from the Faculty of Medicine at the University of Heidelberg. In 2001 he joined the Department of Mathematics and Statistics at Lancaster University as NHS Training Fellow in Medical Statistics and was later promoted to Lecturer in Biostatistics. From 2004 on he worked for Novartis Pharma AG, Basel before joining Warwick Medical School as Associate Professor of Medical Statistics in October 2006.

Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts

Date: 8 October 2024

Journal: European Heart Journal

Thumbnail

Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial

Date: 26 August 2024

Journal: European Heart Journal

Thumbnail

Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?

Date: 17 May 2024

Journal: EP Europace Journal

Thumbnail

Challenges in developing and validating machine learning models for TAVI mortality risk prediction: reply

Date: 8 November 2023

Journal: European Heart Journal - Digital Health

Thumbnail

Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis

Date: 26 August 2023

Journal: European Heart Journal

Thumbnail

Development and validation of explainable machine learning models for risk of mortality in transcatheter aortic valve implantation: TAVI risk machine scores

Date: 17 March 2023

Journal: European Heart Journal - Digital Health

Thumbnail

European Society of Cardiology quality indicators for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed in collaboration with the European Heart Rhythm Association of the European Society of Cardiology

Date: 26 August 2022

Journal: EP Europace Journal

Thumbnail

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial<sup> </sup>

Date: 23 August 2022

Journal: European Heart Journal

Thumbnail

QRS micro-fragmentation as a mortality predictor<sup> </sup>

Date: 21 February 2022

Journal: European Heart Journal

Thumbnail

Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study

Date: 29 November 2021

Journal: EP Europace Journal

Thumbnail

ESC 365 is supported by